- Home
- MYGN vs MAG Comparison
MYGN vs MAG Comparison
Compare MYGN & MAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MYGN
- MAG
- Stock Information
- Founded
- MYGN 1991
- MAG N/A
- Country
- MYGN United States
- MAG Canada
- Employees
- MYGN N/A
- MAG N/A
- Industry
- MYGN Biotechnology: In Vitro & In Vivo Diagnostic Substances
- MAG Precious Metals
- Sector
- MYGN Health Care
- MAG Basic Materials
- Exchange
- MYGN Nasdaq
- MAG Nasdaq
- Market Cap
- MYGN 1.3B
- MAG 1.5B
- IPO Year
- MYGN 1995
- MAG N/A
- Fundamental
- Price
- MYGN $8.80
- MAG $15.46
- Analyst Decision
- MYGN Hold
- MAG Strong Buy
- Analyst Count
- MYGN 15
- MAG 4
- Target Price
- MYGN $20.43
- MAG $18.50
- AVG Volume (30 Days)
- MYGN 875.3K
- MAG 697.9K
- Earning Date
- MYGN 05-06-2025
- MAG 05-13-2025
- Dividend Yield
- MYGN N/A
- MAG 1.17%
- EPS Growth
- MYGN N/A
- MAG 59.57
- EPS
- MYGN N/A
- MAG 0.75
- Revenue
- MYGN $837,600,000.00
- MAG N/A
- Revenue This Year
- MYGN $3.03
- MAG N/A
- Revenue Next Year
- MYGN $8.31
- MAG N/A
- P/E Ratio
- MYGN N/A
- MAG $20.56
- Revenue Growth
- MYGN 11.21
- MAG N/A
- 52 Week Low
- MYGN $8.53
- MAG $10.92
- 52 Week High
- MYGN $29.30
- MAG $18.27
- Technical
- Relative Strength Index (RSI)
- MYGN 27.06
- MAG 47.21
- Support Level
- MYGN $8.53
- MAG $14.84
- Resistance Level
- MYGN $10.30
- MAG $16.89
- Average True Range (ATR)
- MYGN 0.44
- MAG 0.80
- MACD
- MYGN -0.01
- MAG -0.09
- Stochastic Oscillator
- MYGN 15.08
- MAG 24.70
About MYGN Myriad Genetics Inc.
Myriad Genetics is a molecular diagnostics company that provides testing services designed to assess an individual's risk of developing a disease. The firm produces MyRisk, a 48-gene panel with the capability to identify the elevated risk of developing 11 types of cancer. Other diagnostic products include BRACAnalysis CDx, the FDA-approved companion diagnostic for PARP inhibitors; GeneSight, which helps improve responses to psychotropic drugs for patients suffering from depression; and Prequel, a noninvasive prenatal test. Precise Oncology Solutions, launched in 2022, combines Precise Tumor with companion diagnostic and prognostic tests such as MyChoice CDx, Prolaris, and EndoPredict. The firm offers biomarker discovery and companion diagnostic services to pharma and biotech companies.
About MAG MAG Silver Corporation
MAG Silver Corp is a Canadian mining company. It is focused on advancing high-grade, district-scale precious metals projects in the Americas. The Company's principal asset is in the Juanicipio Mine located in Zacatecas, Mexico, which achieved commercial production of around 4,000 tonnes per day. The company has also Interest in the Larder project. Also, MAG has an expanded exploration program targeting multiple prospective targets at both Juanicipio and the Deer Trail 100% earn-in project in Utah. The Juanicipio Mine recognizes revenue for silver, gold, lead, and zinc from concentrate sales.